NEW YORK ( TheStreet) -- As 2009 is coming to an end, we have watched the equity markets rally by over 30% and gold hit all-time highs. Additionally, signs of a global economic recovery have emerged and the future of the biotechnology, energy and materials sectors remains bright.

Biotechnology

Despite much uncertainty in the massive health care reform bill that is making its way through the legislative process, it is a safe bet to say that some sort of the bill will be passed. With this in mind, heavy regulation and tax bills will likely hit Big Pharma, but not the biotech sector. As a result, massive amounts of cash could flow into biotech. Additionally, not all biotech companies have rallied from March lows and valuations for some are relatively still reasonable.

An ETF to watch is the PowerShares Dynamic Biotech & Genome ( PBE), which is up 51% from its March low of $11.03 and closed at $16.65 on Tuesday.

Energy

As the world's economy is expected to continue to rebound through 2010, the demand for energy, in particularl oil, is likely to increase. China, India, Brazil and the U.S. are all expected to show economic growth in 2010, which will spur demand for energy, while production is expected to remain steady. They key place to focus on in the energy sector is exploration and production.

An ETF to watch here is the iShares Dow Jones US Oil & Gas Exploration Index ( IEO). IEO is up 80% from a March low of $30.17 to close at $54.30 on Tuesday.

Materials

Much like the energy sector, as global economies start to rebound and expand, basic materials will be in demand. Many countries, like China and the United States, are focusing on improving infrastructure which will likely spur the demand for steel, aluminum, copper and other building materials. An ETF to watch here is the iShares S&P Global Materials ( MXI), up 43% year to date.

If you liked this article you might like

Amazon, Apple and Chipotle Too Pricey for Your Portfolio? There's an ETF for That

Dion's Weekly Winners and Losers

Dion's Weekly Winners and Losers

A Biotech ETF for Any Risk Level

A Biotech ETF for Any Risk Level

Is Your Biotech ETF a Leader or Laggard?

Is Your Biotech ETF a Leader or Laggard?

Don Dion's Weekly ETF Blog Wrap

Don Dion's Weekly ETF Blog Wrap